The DOI matches its Crossref record; 431 of the 431 references it cites were found in a registry or an index.
Cardiovascular Actions of Insulin
Abstract
Insulin has important vascular actions to stimulate production of nitric oxide from endothelium. This leads to capillary recruitment, vasodilation, increased blood flow, and subsequent augmentation of glucose disposal in classical insulin target tissues (e.g., skeletal muscle). Phosphatidylinositol 3-kinase-dependent insulin-signaling pathways regulating endothelial production of nitric oxide share striking parallels with metabolic insulin-signaling pathways. Distinct MAPK-dependent insulin-signaling pathways (largely unrelated to metabolic actions of insulin) regulate secretion of the vasoconstrictor endothelin-1 from endothelium. These and other cardiovascular actions of insulin contribute to coupling metabolic and hemodynamic homeostasis under healthy conditions. Cardiovascular diseases are the leading cause of morbidity and mortality in insulin-resistant individuals. Insulin resistance is typically defined as decreased sensitivity and/or responsiveness to metabolic actions of insulin. This cardinal feature of diabetes, obesity, and dyslipidemia is also a prominent component of hypertension, coronary heart disease, and atherosclerosis that are all characterized by endothelial dysfunction. Conversely, endothelial dysfunction is often present in metabolic diseases. Insulin resistance is characterized by pathway-specific impairment in phosphatidylinositol 3-kinase-dependent signaling that in vascular endothelium contributes to a reciprocal relationship between insulin resistance and endothelial dysfunction. The clinical relevance of this coupling is highlighted by the findings that specific therapeutic interventions targeting insulin resistance often also ameliorate endothelial dysfunction (and vice versa). In this review, we discuss molecular mechanisms underlying cardiovascular actions of insulin, the reciprocal relationships between insulin resistance and endothelial dysfunction, and implications for developing beneficial therapeutic strategies that simultaneously target metabolic and cardiovascular diseases.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 401–431 of 431
Insulin increases vascular smooth muscle recovery from intracellular calcium loads.
Kim, Y. C., & Zemel, M. B. (1993) · Hypertension · doi:10.1161/01.hyp.22.1.74 · Cited by 39
Noninvasive Doppler assessment of human postprandial renal blood flow and cardiac output
Avasthi, P., Greene, E. R., & Voyles, W. F. (1987) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.1987.252.6.f1167 · Cited by 39
Insulin does not reduce forearm alpha-vasoreactivity in obese hypertensive or lean normotensive men.
Neahring, J. M., Stepniakowski, K. T., Greene, A. S., & Egan, B. M. (1993) · Hypertension · doi:10.1161/01.hyp.22.4.584 · Cited by 38
Wallis, M. G., Smith, M. E., Kolka, C. M., Zhang, L., Richards, S. M., Rattigan, S., & Clark, M. G. (2005) · Diabetologia · doi:10.1007/s00125-005-1887-z · Cited by 38
Perticone, F., Sciacqua, A., Scozzafava, A., Ventura, G., Laratta, E., Pujia, A., Federici, M., Lauro, R., & Sesti, G. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-032161 · Cited by 38
Schnyder, B., Pittet, M., Durand, J., & Schnyder‐Candrian, S. (2002) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00050.2001 · Cited by 37
Laine, H. K., Knuuti, J. M., Ruotsalainen, U., Raitakari, M., Iida, H., Kapanen, J., Kirvelä, O., Haaparanta‐Solin, M., Yki‐Järvinen, H., & Nuutila, P. (1998) · Journal of Hypertension · doi:10.1097/00004872-199816020-00012 · Cited by 36
Jackson, R. A., HAMLING, J. B., BLIX, P. M., Sim, B. M., Hawa, M. I., Jaspan, J. B., BELIN, J., & Nabarro, J. D. N. (1986) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-63-3-594 · Cited by 34
Laine, H. K. (2000) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.85.5.1868 · Cited by 34
Ueda, S., Petrie, J. R., Cleland, S. J., Elliott, H. L., & Connell, J. (1998) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.83.6.4897 · Cited by 33
Participation of PI3K and atypical PKC in Na+-K+-pump stimulation by IGF-I in VSMC
Li, D., Sweeney, G., Wang, Q., & Klip, A. (1999) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.1999.276.6.h2109 · Cited by 33
Utriainen, T., Mäkimattila, S., Virkamäki, A., Lindholm, H. J., Sovijärvi, A. R. A., & Yki-Järvinen, H. (1996) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.81.12.8954024 · Cited by 30
Chisalita, S. I., & Arnqvist, H. J. (2005) · Diabetologia · doi:10.1007/s00125-005-1890-4 · Cited by 29
Contribution of blood flow to leg glucose uptake during a mixed meal
Hernandez Mijares, A., & Jensen, M. D. (1995) · Diabetes · doi:10.2337/diabetes.44.10.1165 · Cited by 29
Insulin-mediated vasodilation: why one's physiology could be the other's pharmacology
Available, N. A. N. (1999) · Diabetologia · doi:10.1007/s001250051184 · Cited by 29
Phosphoinositide 3-kinase regulates excitation-contraction coupling in neonatal cardiomyocytes
McDowell, S. A., McCall, E. J., Matter, W. F., Estridge, T. B., & Vlahos, C. J. (2004) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00546.2003 · Cited by 27
Ren, J. T., Sowers, J. R., Natavio, M. F. Q., & Brown, R. A. (1999) · Proceedings of The Society for Experimental Biology and Medicine · doi:10.1046/j.1525-1373.1999.d01-53.x · Cited by 26
Dick, G. M., & Sturek, M. S. (1996) · Diabetes · doi:10.2337/diab.45.7.876 · Cited by 26
Insulin sensitivity and big ET-1 conversion to ET-1 after ETA- or ETB-receptor blockade in humans
AHLBORG, G., & Lindström, J. (2002) · Journal of Applied Physiology · doi:10.1152/japplphysiol.00477.2002 · Cited by 26
Wiecha, J., Reineker, K., Reitmayer, M., et al. (1998) · Growth Hormone & IGF Research · doi:10.1016/s1096-6374(98)80108-1 · Cited by 23
Ihlemann, N., Stokholm, K. H., & ESKILDSEN, P. (2002) · Diabetic Medicine · doi:10.1046/j.1464-5491.2002.00715.x · Cited by 21
Slimani, L., Oikonen, V., Hällsten, K., Savisto, N., Knuuti, J. M., Nuutila, P., & Iozzo, P. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-0269 · Cited by 20
Davidoff, A. J. (2006) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/j.1440-1681.2006.04343.x · Cited by 20
Insulin signaling in the vasculature
Begum, N. (2003) · Frontiers in bioscience · doi:10.2741/1146 · Cited by 15
Ren, J. T., Sowers, J. R., Natavio, M. F. Q., & Brown, R. A. (1999) · Experimental Biology and Medicine · doi:10.3181/00379727-221-44383 · Cited by 14
Function determines structure in the vasculature: lessons from insulin resistance
Mather, K. J., & Verma, S. (2005) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00297.2005 · Cited by 11
Touyz, R. M., Tolloczko, B., & Schiffrin, E. L. (1995) · American Journal of Hypertension · doi:10.1016/0895-7061(94)00173-9 · Cited by 11
Cholinergic Involvement in Vascular and Glucoregulatory Actions of Insulin in Rats
Lévesque, M., Santuré, M., Pǐtre, M., Nadeau, A., & Bachelard, H. (2006) · Diabetes · doi:10.2337/diabetes.55.02.06.db05-0684 · Cited by 9
Insulin action and skeletal muscle blood flow in patients with Type 1 diabetes and microalbuminuria
Wiggam, M. I., Hunter, S. J., Ennis, C. N., Sheridan, B., Atkinson, A. B., & Bell, P. M. (2001) · Diabetes Research and Clinical Practice · doi:10.1016/s0168-8227(01)00244-3 · Cited by 9
Rizza, S., Tesauro, M., Cardellini, M., Menghini, R., Bellia, A., Marini, M. A., Lauro, D., Sbraccia, P., Sesti, G., Lauro, R., et al. (2006) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000196552.84475.fc · Cited by 9
O'Callaghan, C. J., Komersova, K., Krum, H., & Louis, W. J. (1997) · Clinical Science · doi:10.1042/cs0930535 · Cited by 6
Cited by
Muniyappa, R., Lee, S., Chen, H., & Quon, M. J. (2008) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00645.2007 · Cited by 1,643
“In addition to these classical insulin target tissues, there are many other important physiological targets of insulin including the brain, pancreatic beta cells, heart, and vascular endothelium that help to coordinate and couple metabolic and cardiovascular homeostasis under healthy conditions (4, 54, 72, 79).”
BackgroundSelf-citationLow Wang, C. C., Hess, C. N., Hiatt, W. R., & Goldfine, A. B. (2016) · Circulation · doi:10.1161/circulationaha.116.022194 · Cited by 1,155
Role of Mitochondrial Dysfunction in Insulin Resistance
Kim, J.-A., Wei, Y., & Sowers, J. R. (2008) · Circulation Research · doi:10.1161/circresaha.107.165472 · Cited by 1,103
Preiser, J.-C., Devos, P., Ruiz-Santana, S., Mélot, C., Annane, D., Groeneveld, J., Iapichino, G., Leverve, X., Nitenberg, G., Singer, P., et al. (2009) · Intensive Care Medicine · doi:10.1007/s00134-009-1585-2 · Cited by 911
Endothelial dysfunction — A major mediator of diabetic vascular disease
Sena, C. M., Pereira, A. M., & Seiça, R. (2013) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2013.08.006 · Cited by 797
Metadata
- Authors
- Muniyappa, R., Montagnani, M., Koh, K. K., & Quon, M. J.
- Venue
- Endocrine Reviews
- Publisher
- The Endocrine Society
- Published
- 2007-08-01
- Volume
- 28
- Issue
- 5
- Pages
- 463-491
- ISSN
- 0163-769X (ISSN-L)
- 1945-7189
- OpenAlex
- W2150429576
- Cited by
- 872
- References
- 431
- FWCI
- 28.67
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.